One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood-2020-133820
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 46 |
Affiliation: Copenhagen University Hospital, University Medical Center Utrecht, Vejle Sygehus, University of Southampton, Cancer Research UK, The Christie NHS Foundation Trust, Hovon, University of Plymouth, Institut Català d'Oncologia, Duran i Reynals Hospital, Royal Marsden NHS Foundation Trust, Genmab (Denmark), Genmab (United States), Erasmus MC Cancer InstituteSubcutaneous Epcoritamab Induces Complete Responses with an Encouraging Safety Profile across Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Subtypes, Including Patients with Prior CAR-T Therapy: Updated Dose Escalation Data
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
